PND8 - PEGINTERFERON BETA-1A IS ASSOCIATED WITH REDUCED RELAPSE RATES AND HOSPITALISATIONS DUE TO RELAPSE COMPARED WITH OTHER FIRST-LINE INJECTABLE THERAPIES FOR MULTIPLE SCLEROSIS- FINDINGS FROM A REAL-WORLD CROSS-SECTIONAL STUDY
Abstract
Authors
F Hammes J Pike E Jones J Husbands A Harrington